The payment is to resolve allegations that the generic drug manufacturer submitted false claims and violated a federal law that prohibits the payment of kickbacks to generate federal healthcare business or induce patient referrals.
Related Posts
How the Justice Department Is Changing Its Tactics on Cybercrime
The assistant U.S. attorney general for national security outlines where the biggest threats are coming from—and what kinds of attacks are most worrisome
Brunello Cucinelli Sees Robust Growth in Coming Years Despite Luxury Slowdown
- staff
- January 13, 2025
- 0
The company said it benefits from ultra-high net worth clients, who continued to indulge in luxury shopping even as a tough macroeconomic environment hit less […]
Auto & Transport Roundup: Market Talk
- staff
- January 24, 2025
- 0
Read about CSX, Magna International, Alaska Air and more in the latest Market Talks covering the auto and transport sector.